USPTO TTABVUE. Trademark Trial and Appeal Board Inquiry System

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

TTABVUE. Trademark Trial and Appeal Board Inquiry System

v2.5.0

Summary

Query: Party Name contains all words: PHARMACEUTICALS INC
Number of results: 676+
Results are in reverse chronological order

Proceeding
Filing Date

Defendant(s),
Property(ies)

Plaintiff(s),
Property(ies)

91232010
12/30/2016

Merck Sharp & Dohme Corp.
Mark: ZIVENBA S#:86922579

Jazz Pharmaceuticals, Inc.
Mark: XYREM S#:78400994 R#:3112732
Mark: XYREM S#:75123252 R#:2249959
Mark: XYREM S#:75577530 R#:2423880
Mark: XYREM S#:75701032 R#:2472156
Mark: XYREM S#:76327130 R#:2860730
Mark: XYREM S#:78769796 R#:3309255
Mark: XYREM S#:78769619 R#:3162632
Mark: XYREM SUCCESS PROGRAM S#:76397391 R#:2867332
Mark: XYREM PATIENT SUCCESS PROGRAM S#:76412893 R#:2848521
Mark: XYREM SUCCESS PROGRAM FOR PHYSICIANS S#:76412894 R#:2860906
Mark: XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII S#:76427104 R#:2952351
Mark: XYREM S#:78769631 R#:3162636

87076564
01/23/2017

Praza LLC
Mark: ZYNEV S#:87076564

Jazz Pharmaceuticals, Inc.

87073997
12/15/2016

Glaxo Group Limited
Mark: ZYRKINUS S#:87073997

JAZZ PHARMACEUTICALS, INC.

87146201
12/08/2016

GENENTECH, INC.
Mark: XIBIXI S#:87146201

JAZZ PHARMACEUTICALS, INC.

87061053
12/08/2016

NEXT GEN HEALTH SOLUTIONS, LLC
Mark: RED FORTERA S#:87061053

Endo Pharmaceuticals, Inc.

86852106
11/27/2016

Boehringer Ingelheim Pharmaceuticals, Inc.
Mark: BREATHLESS S#:86852106

86751997
11/23/2016

Keystone Pharmaceuticals, Inc.
Mark: KEYSTONE PHARMACEUTICALS, INC. S#:86751997

Ecolab USA Inc.

91231398
11/23/2016

Tetraphase Pharmaceuticals, Inc.
Mark: XYRAVIO S#:86846265

Jazz Pharmaceuticals, Inc.
Mark: XYREM S#:75123252 R#:2249959
Mark: XYREM S#:75577530 R#:2423880
Mark: XYREM S#:75701032 R#:2472156
Mark: XYREM S#:76327130 R#:2860730
Mark: XYREM S#:78769796 R#:3309255
Mark: XYREM S#:78400994 R#:3112732
Mark: XYREM SUCCESS PROGRAM S#:76397391 R#:2867332
Mark: XYREM PATIENT SUCCESS PROGRAM S#:76412893 R#:2848521
Mark: XYREM SUCCESS PROGRAM FOR PHYSICIANS S#:76412894 R#:2860906
Mark: XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII S#:76427104 R#:2952351
Mark: XYREM S#:78769631 R#:3162636

86845666
11/23/2016

IONIS PHARMACEUTICALS, INC.
Mark: IONIS PHARMACEUTICALS S#:86845666

Incline Therapeutics, Inc.
The Medicines Company

86845669
11/23/2016

IONIS PHARMACEUTICALS, INC.
Mark: IONIS PHARMACEUTICALS S#:86845669

Incline Therapeutics, Inc.
The Medicines Company

86838402
11/23/2016

IONIS PHARMACEUTICALS, INC.
Mark: IONIS PHARMACEUTICALS S#:86838402

Incline Therapeutics, Inc.
The Medicines Company

86838421
11/23/2016

IONIS PHARMACEUTICALS, INC.
Mark: IONIS PHARMACEUTICALS S#:86838421

The Medicines Company
Incline Therapeutics, Inc.

87040531
11/17/2016

Juno Therapeutics, Inc.
Mark: XELLUNO S#:87040531

Lexicon Pharmaceuticals, Inc.

91230828
10/26/2016

Aspen Park Pharmaceuticals Inc.
Mark: VERU PHARMA S#:87004711

Shire ViroPharma Incorporated
Mark: VIROPHARMA S#:75168899 R#:2459907
Mark: VIROPHARMA INCORPORATED S#:75168901 R#:2457511
Mark: VIROPHARMA BIOLOGICS S#:77644296 R#:3948243

91230516
10/10/2016

PARI Pharma GmbH
Mark: ZIRELA S#:86093974

Jazz Pharmaceuticals, Inc.
Mark: XYREM S#:78400994 R#:3112732
Mark: XYREM S#:75123252 R#:2249959
Mark: XYREM S#:75577530 R#:2423880
Mark: XYREM S#:75701032 R#:2472156
Mark: XYREM S#:76327130 R#:2860730
Mark: XYREM S#:78769796 R#:3309255
Mark: XYREM SUCCESS PROGRAM S#:76397391 R#:2867332
Mark: XYREM PATIENT SUCCESS PROGRAM S#:76412893 R#:2848521
Mark: XYREM SUCCESS PROGRAM FOR PHYSICIANS S#:76412894 R#:2860906
Mark: XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII S#:76427104 R#:2952351
Mark: XYREM S#:78769631 R#:3162636

86618301
10/05/2016